Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine
- 15 May 1994
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 29 (2) , 407-412
- https://doi.org/10.1016/0360-3016(94)90299-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Distribution of etanidzole into human brain tumors: Implications for treating high grade gliomasInternational Journal of Radiation Oncology*Biology*Physics, 1992
- The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: Results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Depletion of Glutathione in Normal and Malignant Human Cells In Vivo by Buthionine Sulfoximine: Clinical and Biochemical ResultsJNCI Journal of the National Cancer Institute, 1992
- Elevation of mouse kidney thiol content following administration of glutathioneRadiotherapy and Oncology, 1992
- The management of malignant gliomas with radiation therapy: Therapeutic results and research strategiesSeminars in Radiation Oncology, 1991
- L-Buthionine-Sulfoximine-Mediated Radiosensitization in Experimental Interstitial Radiotherapy of Intracerebral D-54 MG Glioma Xenografts in Athymic MiceNeurosurgery, 1990
- Role of glutathione in the radiation response of mammalian cells invitro and in vivoPharmacology & Therapeutics, 1990
- Combined radiation-protective and radiation-sensitizing agents IV: Measurement of intracellular protector concentrationsInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Effect of Fluosol-DA® on the response of intracranial 9L tumors to X rays and BCNUInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Detection and Quantitation of Biological SulfhydrylsPublished by Wiley ,1988